Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
nomics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes best progress fir
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
nomics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes best progress fir
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
nomics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes best progress fir
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
nomics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes best progress fir
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Justin Quinn
Jeffrey Epstein
PERSON7 w/ Amyris·4 w/ Justin
Marc Rich
PERSON7 w/ Amyris·4 w/ Justin
MM
Margo Monroe
PERSON4 w/ Amyris·4 w/ Justin
Robert Gates
PERSON4 w/ Amyris·4 w/ Justin
Justin Trudeau
PERSON4 w/ Amyris·4 w/ Justin
JC
James Clement
PERSON4 w/ Amyris·4 w/ Justin
KE
Kevin Esvelt
PERSON4 w/ Amyris·4 w/ Justin
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Justin
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Justin
DM
Dan Mandell
PERSON4 w/ Amyris·4 w/ Justin
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Justin
BD
Bobby Dhadwar
PERSON4 w/ Amyris·4 w/ Justin
TW
Ting Wu
PERSON4 w/ Amyris·4 w/ Justin
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Justin
ES
Eswar
PERSON3 w/ Amyris·3 w/ Justin
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Justin
Eric Trump
PERSON3 w/ Amyris·2 w/ Justin
HE
Helicos
PERSON2 w/ Amyris·2 w/ Justin